Atlas Trials

The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflozin

Clinical trial NCT03895229 · COMPLETED

Trial details

NCT number
NCT03895229
Sponsor
Ain Shams University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes MellitusPharmacokineticsPharmacodynamics
Start date
2018-10-01
Primary completion
2018-10-19
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.